AI Analysis

How does BAFNAPH.NS make money? Does BAFNAPH.NS have pricing power? What's the Earnings Whisper? Will BAFNAPH.NS profit more as the business scales? What is BAFNAPH.NS's management track record? Is BAFNAPH.NS's current price justified?

Bafna Pharmaceuticals Limited

₹461.35 +$312.96 (+210.90%)

NSE · 16 Oct 2026 09:44 UTC

Previous Close

₹452.35

Day Range

₹460₹461.35

Year Range

₹94.77₹461.35

Market Cap

10.91B

AVG Volume

18.28K

Trailing/Forward PE

140.23/-

PEG ratio

-24.47

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

BAFNAPH.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	1.44B
26 Q4	1.51B
26 Q3	1.47B
26 Q2	1.42B
26 Q1	1.47B
25 Q4	1.46B
25 Q3	1.48B
25 Q2	1.43B
25 Q1	1.44B
24 Q4	1.52B

Net Income (INR) · TTM

BAFNAPH.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	77.86M
26 Q4	111M
26 Q3	96.62M
26 Q2	87.72M
26 Q1	82.65M
25 Q4	41.52M
25 Q3	42.97M
25 Q2	4.07M
25 Q1	2.73M
24 Q4	73.48M

Operating Income (INR) · TTM

BAFNAPH.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	115.56M
26 Q4	98.75M
26 Q3	108.85M
26 Q2	108.11M
26 Q1	102.19M
25 Q4	62.87M
25 Q3	50.07M
25 Q2	2.55M
25 Q1	8M
24 Q4	61.16M

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Bafna Pharmaceuticals Limited

Video analysis: BAFNAPH.NS

News: BAFNAPH.NS

Similar companies